Related Experiment Video
Updated: Apr 28, 2026

Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
Published on: February 14, 2020
Advanced protein glycosylation in diabetes and aging
1Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Abstract:
Products of advanced protein glycosylation (advanced glycation end products, or AGEs) accumulate in tissues as a function of time and sugar concentration. AGEs induce permanent abnormalities in extracellular matrix component function, stimulate cytokine and reactive oxygen species production through AGE-specific receptors, and modify intracellular proteins. Pharmacologic inhibition of AGE formation in long-term diabetic animals prevents diabetic retinopathy, nephropathy, neuropathy, and arterial abnormalities in animal models. Clinical trials in humans are currently in progress.
Insights
Advanced glycation end products (AGEs) accumulate with age and high sugar, causing tissue damage. Inhibiting AGE formation in diabetic animals prevented complications, with human trials underway.
Area of Science:
- Biochemistry
- Pathophysiology
- Endocrinology
Background:
- Advanced glycation end products (AGEs) are formed from protein glycation.
- AGE accumulation is linked to aging and hyperglycemia.
- AGEs cause cellular dysfunction and tissue damage.
Purpose of the Study:
- To investigate the role of AGEs in diabetic complications.
- To evaluate the therapeutic potential of AGE formation inhibitors.
Main Methods:
- Studies involved long-term diabetic animal models.
- Pharmacologic inhibition of AGE formation was employed.
- Assessment of various diabetic pathologies was performed.
Main Results:
- Inhibition of AGE formation prevented diabetic retinopathy.
- Nephropathy, neuropathy, and arterial abnormalities were also prevented.
- These findings highlight the detrimental effects of AGEs.
Conclusions:
- AGEs play a critical role in the pathogenesis of diabetic complications.
- Pharmacologic inhibition of AGE formation is a promising therapeutic strategy.
- Further clinical investigation in humans is warranted.
More Related Videos
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Type II Diabetes II: Pathophysiology
Complications of Diabetes Mellitus
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Neuropathy